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We report a case of recurrent renal cancer in the autografted kidney, treated with percutaneous
cryoablation. A 59-year-old man who had bilateral renal tumors underwent radical left nephrectomy, ex
vivo right partial nephrectomy and auto-transplantation at the right ileal fossa in our hospital 11 years ago.
Histopathological examination showed clear cell renal cell carcinoma in bilateral kidneys (pT1bN0M0). He
had been followed at another hospital without tumor recurrence for 11 years. In 2014, an enhanced CT
scan revealed a renal tumor with a diameter of two centimeters in the autografted kidney, which was thought
to be a recurrence of the initial renal cancer. He was referred to our hospital for further evaluation and
treatment. He underwent percutaneous renal tumor biopsy, which conﬁrmed renal cancer recurrence,
followed by percutaneous cryoablation. Three months after cryoablation, an enhanced CT showed that the
enhancement lesion in the autografted kidney had disappeared, and these ﬁndings were conﬁrmed
pathologically by absence of malignancy by a subsequent needle biopsy. The level of serum creatinine (sCr)
was 1.16 md/dl immediately before cryoablation and 1.46 mg/dl at three months after cryoablation. Nine
months after cryoablation, the patient had no reccurence and renal function was stable (sCr 1.43 mg/dl).
(Hinyokika Kiyo 62 : 539-543, 2016 DOI : 10.14989/ActaUrolJap_62_10_539)











患 者 : 59歳，男性






れぞれ径 65，20，12 mm の腫瘍を 3つ，右腎に径 45







造影 CT で自家移植腎に造影効果を伴う径 2 cm 大の
腫瘤を認め，腎癌の再発が疑われ，精査加療目的に当
科紹介受診となった．
現症および検査所見 : 身長 163.8 cm，体重 67 kg，
体温 35.7°C，血圧 137/93 mmHg，脈拍回79/分．
腹部正中切開痕，右傍腹直筋切開痕を認める以外に
特記すべき身体所見なし．







Fig. 1. A, B) Abdominal enhanced CT scan
showing three tumors (65, 20, 12 mm) in the
left kidney. C) Abdominal enhanced CT






Fig. 2. Abdominal enhanced CT scan showing a
renal mass. A) Early phase, B) late phase.
泌62,08,0◆-3
Fig. 3. Clear cell carcinoma of biopsy specimens (H
& E staining).
末梢血液検査 : WBC 5,060/mm3，Hb 16.1 g/dl，
Ht 48.2％，PLT 13.9×104/mm3
血液生化学検査 : BUN 17 mg/dl，Cr 1.05 mg/dl，
AST 20 IU/l，ALT 13 IU/l，LDH 197 IU/l，CRP 0.08
mg/dl
画像検査所見 : 腹部造影 CT で自家移植腎に早期相









社製の CryoHit を用い，CT ガイド下に 17 G IceRod
ニードルを 3本腫瘍内に穿刺し，凍結15分間と解凍 5
分間を 2回繰り返し，治療を行った．術中，CT で腫
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泌62,08,0◆-4
Fig. 4. Abdominal CT scan during percutaneous
cryoablation showed whole tumor being in
the ICE ball.
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Fig. 5. Abdominal enhanced CT scan showed
disappearance of enhancement.
瘍全体が確実に凍結範囲に含まれていることを確認し




は 1.16 mg/dl であり，治療 2日目に 1.58 mg/dl， 3
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Table 1. Clinical features of four solitary kidney patients treated with percutaneous cryoablation therapy in our
hospital
年齢性別 腫瘍径（mm)
血清 Cr 値（mg/dl) eGFR（ml/min/1.73m2)
転帰
治療前 治療後 上昇率（％) 治療前 治療後 低下率（％)
76M 25 1.24 1.73 39.5 44.2 30.7 30.5 11カ月 NED
78M 21 1.72 2.46 43.0 30.7 20.8 32.2 11カ月 NED
67M 30 1.60 1.98 23.8 34.9 27.6 20.9 10カ月 NED
60M
(本症例) 22 1
.16 1.46 25.9 50.9 39.6 22.2 10カ月 NED
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